Determinants of Direct Discharge Home From Critical Care Units: A Population-Based Cohort Analysis.


Journal

Critical care medicine
ISSN: 1530-0293
Titre abrégé: Crit Care Med
Pays: United States
ID NLM: 0355501

Informations de publication

Date de publication:
04 2020
Historique:
entrez: 25 3 2020
pubmed: 25 3 2020
medline: 10 2 2021
Statut: ppublish

Résumé

To describe trends and patient and system factors associated with direct discharge from critical care to home in a large health system. Population-based cohort study of direct discharge to home rates annually over 10 years. We used a multivariable, multilevel random-effects regression model to analyze current factors associated with direct discharge home in a subcohort from the most recent 2 years. One hundred seventy-four ICUs in 101 hospitals in Ontario. All patients discharged from an ICU between April 1, 2007, and March 31, 2017. None. Overall, 237,200 patients (21.1%) were discharged directly home from an ICU. The rate of direct discharge to home increased from 18.6% in 2007 to 23.1% in 2017 (annual increase of 1.02; 95% CI, 1.02-1.03). There were marked variations in rates of direct discharge to home across all critical care units. For medical and surgical units, the median odds ratio was 1.76 (95% CI, 1.59-1.92). In these units, direct discharge to home was associated with younger age (odds ratio, 0.36; 95% CI, 0.34-0.39 for age 80-105 vs age 18-39), fewer comorbidities (odds ratio, 1.74; 95% CI, 1.63-1.85 for Charlson comorbidity index of 0 vs 2), diagnoses of overdose/poisoning (odds ratio, 1.35; 95% CI, 1.23-1.47) and diabetic complications (odds ratio, 1.35; 95% CI, 1.2-1.51), and admission after a same-day procedure (odds ratio, 2.82; 95% CI, 2.46-3.23 compared with emergency department). ICU occupancy was inversely associated with direct discharge to home with an odds ratio of 0.88 (95% CI, 0.87-0.88) for each 10% increase. High rates of direct discharge to home with evidence of significant practice variation combined with identifiable patient characteristics suggest that further evaluation of this increasingly common transition in care is warranted.

Identifiants

pubmed: 32205593
doi: 10.1097/CCM.0000000000004178
pii: 00003246-202004000-00005
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

475-483

Subventions

Organisme : CIHR
Pays : Canada

Commentaires et corrections

Type : CommentIn

Auteurs

Claudio M Martin (CM)

Division of Critical Care, Department of Medicine, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada.
Lawson Health Research Institute, London, ON, Canada.

Melody Lam (M)

ICES Western, London, ON, Canada.

Britney Allen (B)

ICES Western, London, ON, Canada.

Lucie Richard (L)

ICES Western, London, ON, Canada.

Vincent Lau (V)

Division of Critical Care, Department of Medicine, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada.

Ian M Ball (IM)

Division of Critical Care, Department of Medicine, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada.
Lawson Health Research Institute, London, ON, Canada.
Department of Epidemiology and Biostatistics, Western University, London, ON, Canada.

Hannah Wunsch (H)

Interdepartmental Division of Critical Care, University of Toronto, Toronto, ON, Canada.
Department of Critical Care Medicine, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.
ICES, Toronto, ON, Canada.

Rob A Fowler (RA)

Interdepartmental Division of Critical Care, University of Toronto, Toronto, ON, Canada.
Department of Critical Care Medicine, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.
ICES, Toronto, ON, Canada.

Damon C Scales (DC)

Interdepartmental Division of Critical Care, University of Toronto, Toronto, ON, Canada.
Department of Critical Care Medicine, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.
ICES, Toronto, ON, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH